Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001593968-23-001008

Options or other derivatives

  • Director acquired 116,120 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mayo Stephen · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +116,120 116,120 D
Loading xslF345X04/primary_01.xml…